Authors


Joni Meehan, BS

Latest:

The Importance of Maintaining Antibiotic Breakpoints

Laboratories that use revised carbapenem breakpoints detect significantly more carbapenem-resistant Enterobacteriaceae than laboratories that use historical ones.


Jackie Syrop

Latest:

Benefits of Azithromycin Outweigh Risks in Elderly Hospitalized with Pneumonia

Among patients aged 65 years or older who are hospitalized with community-acquired pneumonia, azithromycin lowers the risk of 90-day mortality in exchange for slightly increased odds of myocardial infarction compared to other antibiotic regimens.



MICHAEL CRAIG, MPP

Latest:

Five Ways ID Clinicians Can Take On Antibiotic Resistance: Highlights From the CDC's Latest Report

A death from an antibiotic-resistant infection occurs about every 15 minutes in the United States. The CDC’s 2019 threat report dives into national infection estimates and actions we can take to combat this threat.


George Citroner

Latest:

About Half of Millennials Are Not Getting Tested For HIV

A recent CDC report finds those between 15 and 44 years of age are significantly more likely to have never been tested for HIV.


Ron Chappuis

Latest:

Accurate Data Is Key in Raising Hand Hygiene Compliance and Improving Patient Safety

The Joint Commission considers hand hygiene the most important intervention for preventing healthcare-associated infections, which are responsible for 75,000 deaths annually.



KARAM MOUNZER, MD

Latest:

Addressing Weight Gain That Follows Life-Saving Antiretroviral Therapy

Clinicians must identify when additional pounds cross the line of diminishing return.


Audrey M. Stevenson PhD, MPH, FNP-BC

Latest:

Taking Action to Address Critical Gaps in Teen Immunization

According to recent data from the Centers for Disease Control and Prevention, millions of Americans aged 13-17 are under-vaccinated against serious infectious diseases.


CHRISTOPHER B. HURT, MD

Latest:

The State of PrEP in 2017: Recent Data and Current Challenges

Although a once-daily pill to prevent HIV exists, US populations at highest risk have the lowest rates of usage.


Mai-Chi N. Tran, PharmD, BCPS

Latest:

Investigational Treatments for Clostridioides difficile Infection

The high recurrence rates of Clostridioides difficile infection highlight the need for novel agents with unique mechanisms of action for treating the infection.


Davy James

Latest:

Pharmacists Essential to Combatting Vaccine-Preventable Disease

Pharmacists have the opportunity to take a lead role in providing education on the importance of vaccines in protecting people from preventable illnesses, according to a session which took place at the American Society of Health-System Pharmacists (ASHP) 54th Midyear Clinical Meeting & Exhibition.


Contagion®Editorial Staff

Latest:

Top 5 Contagion&reg News Articles for the Week of June 25, 2017

Measles in Ontario, more endoscope-related infections, a study of postnatal Zika infections, research and development on a river blindness vaccine, and using CRISPR to tackle Zika are the articles that make up this week’s Top 5.


KRISTEN L. BUNNELL, PHARMD, BCCCP

Latest:

5 Emerging Infections to Watch Out For in 2018

These pathogens can cause unique challenges for clinicians.


Elias K. Manavathu, PhD

Latest:

Medical Importance of Microbial Biofilms in the Management of Infectious Diseases

Biofilms are an emerging clinical problem despite the fact that most clinicians don’t even think of biofilms when managing infections.


W. David Hardy, MD

Latest:

HIV Treatment Advice for Community Physicians

Experts provide community physicians treating HIV with practical advice for screening, diagnosing, and managing patients with HIV.


Kenneth Bender, PharmD, MA

Latest:

Antibiotics Ranked by Risk for Serious Cutaneous Adverse Reactions

Study ranks antibiotic classes by risk for rare, life-threatening cutaneous reactions of Stevens-Johnson syndrome and toxic epidermal necrolysis.


Ian Frank, MD

Latest:

HIV Treatment Advice for Community Physicians

Experts provide community physicians treating HIV with practical advice for screening, diagnosing, and managing patients with HIV.


Cornelius J. Clancy, MD

Latest:

Bringing Culture-Independent Diagnostic Tests for Bloodstream Infections Into Rational Patient Management

These tests have the potential to transform patient care and antimicrobial stewardship, but they have not gained widespread acceptance, partly because of uncertainty over how to use them clinically.


Danielle Mroz, MA

Latest:

SVR Possible in PWID Infected With Hepatitis C Virus Despite Imperfect Adherence to Treatment

People who inject drugs who are infected with hepatitis C virus can achieve sustained viral response, despite imperfect adherence, according to the results of a new trial.


Eileen Oldfield

Latest:

Hepatitis C Saliva Tests May Show a False-Negative Result if HIV Is Also Present

Saliva tests for detecting HCV infection may not be the best option for determining infection status.


Gary L. Edwards, MS

Latest:

Utah's Public Health Approach to Recent Hepatitis A Outbreak

In May 2017, a case of hepatitis A was detected in a Salt Lake County hospital. Over the next 20 months, Utah health officials worked to address what ended up being the largest hepatitis A outbreak in the state’s history.



SANDRA MORALES, PHD

Latest:

Bacteriophage-Antibiotic Combinations: A Promising Alternative for Refractory Infections?

Despite the initial abandonment of bacteriophages in most areas of the world, the era of antibiotic resistance has led to a resurgence of phage therapy in clinical practice.


Della Xu, PharmD

Latest:

How Close Are We to a Cure for HIV?

Evolving research has led the infectious diseases community to redefine its definition of cure.


JAMES ROSSI, MD

Latest:

Salt, Ticks, and Lyme: A Case of Lyme Neuroborreliosis Presenting as SIADH

This case report is the fourth documented case of Lyme-induced syndrome of inappro­priate secretion of antidiuretic hormone (SIADH).



SASKIA V. POPESCU, PhD, MPH, MA, CIC

Latest:

Antimicrobial Resistance: A Catastrophic (and Neglected) Biological Threat

With AMR being a global priority, biosecurity-type policy around resistance may be part of the solution.


Kevin Schwartz, MD, MSc, FRCPC

Latest:

"Antibiotic Never Events": The Ideal Target to Reduce Antimicrobial Exposure

By stopping unnecessary antibiotics before they start, clinicians can avoid unnecessary harm to the patient and the population.


Sarah M. Michienzi, PharmD

Latest:

Antiretroviral Stewardship: The Time is Now

In this narrative review of studies evaluating antiretroviral stewardship programs (ARVSPs), we propose core elements for ARVSPs that are based on published evidence, clinical experience, and adapted from antimicrobial stewardship programs.

© 2024 MJH Life Sciences

All rights reserved.